← Back to Bills
HR 6610119th CongressIntroducedHouse

Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Jul 28, 2026
Latest Action Date
Jul 22, 2026

Latest Action

Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The bill titled 'Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]' is a legislative proposal introduced in the House during the 119th Congress. As of the latest update on July 28, 2026, the bill is in process and has been ordered to be reported with amendments by a vote of 40 to 2. However, there is no official summary or full text available to provide detailed information on the bill's specific provisions, objectives, or mechanisms. The bill appears to relate to federal employee health benefit plans and involves pharmacists, but the absence of detailed content limits a comprehensive understanding.

Bottom Line

This bill is under consideration with strong committee support, but due to the lack of detailed information, its specific impacts and provisions remain unclear.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is titled 'Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]' and was introduced in the House during the 119th Congress.
  • As of July 22, 2026, it was ordered to be reported with amendments by a vote of 40 to 2, indicating significant committee approval.
  • No official summary or full text is available, limiting detailed analysis of the bill's content, policy goals, or implementation details.
Who Benefits?

['Federal employees covered under Federal Employee Health Benefit Plans', 'Pharmacists potentially involved in these health benefit plans', 'Health care providers and possibly related health insurance entities']

Potential Concerns

['Lack of available full text and summary restricts understanding of implementation challenges or costs.', 'Unclear authority and oversight mechanisms due to missing detailed provisions.', "Potential policy tradeoffs cannot be assessed without knowledge of the bill's specific measures."]

Political Context

The bill is currently in process within the House of Representatives during the 119th Congress. The strong committee vote (40-2) to report the bill with amendments suggests bipartisan or broad committee support. However, without further legislative history or text, the broader policy context and stakeholder positions remain unspecified.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['Potential changes to federal employee health benefit plans could affect health care delivery and pharmacy services.', 'Amendments to health benefit plans might influence insurance costs or coverage options for federal employees.', "Pharmacists' roles and reimbursement within federal health plans could be impacted, affecting pharmacy practice."]

GovScope Watchdog Notes

Due to the absence of an official summary and full bill text, transparency is limited. Stakeholders and the public lack access to detailed information necessary for informed analysis and oversight. Monitoring future disclosures and amendments will be essential for understanding the bill's full implications.

Passage Likelihood: UnknownConfidence: 40%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready